Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer-Reference-Cited by-同舟云学术

Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer

Published:2021-01 Issue:1 Volume:113 Page:1087-1095
ISSN:0888-7543
Container-title:Genomics
language:en
Short-container-title:Genomics

Author:

Chen Hongjin,Wang Xiaoming,Wu Fubing,Mo Xiao,Hu Chao,Wang Mei,Xu Haojun,Yao Chengyun,Xia Hongping,Lan Linhua

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Genetics

Reference26 articles.

1. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer;Buscail;Nat Rev Gastroenterol Hepatol,2020

2. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer;Nevala-Plagemann;Nat. Rev. Clin. Oncol.,2020

3. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines;van Huijgevoort;Nat Rev Gastroenterol Hepatol,2019

4. Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy;Zhang;Nat. Commun.,2016

5. HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis;Chen;Aging (Albany NY),2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP4-mediated CENPF deubiquitylation regulated tumor metastasis in colorectal cancer;2024-08-21

2. CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma;Angiology;2024-06-19

3. Cell-Cycle-related Protein Centromere Protein F Deficiency Inhibits Cervical Cancer Cell Growth by Inducing Ferroptosis Via Nrf2 Inactivation;Cell Biochemistry and Biophysics;2024-03-27

4. Cell Cycle-Related Centromere Protein F Deficiency Suppresses Ovarian Cancer Cell Growth by Inducing Ferroptosis;Gynecologic and Obstetric Investigation;2024

5. CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes;Nature Communications;2023-10-10